Can NMN Prevent Kidney Scarring in Humans?

Applying this pathway information may help to develop new therapeutic agents to prevent or slow the progression of age-related kidney scarring. It also suggests that increasing NAD+ levels with NMN to stimulate SIRT1 may already offer a means to slow kidney scarring. Determining whether NMN can slow kidney disease progression in humans as it does in rodents will require future clinical trials.
ENGLISH
ENGLISH